Dear colleagues:
A novel international Biotechnology Discussion List (BIZ-BIOTECH) has
been created.
Subscription address: listserv at netcom.com
Biz-biotech owner address: grunwald at netcom.com
Posting address: biz-biotech at netcom.com
* How to SUBSCRIBE to biz-biotech:
Send the following message
SUBSCRIBE BIZ-BIOTECH
to
LISTSERV at NETCOM.COM
* How to UNSUBSCRIBE from biz-biotech:
Send the following message
UNSUBSCRIBE BIZ-BIOTECH
to
LISTSERV at NETCOM.COM
One of the major goals the of BIZ-BIOTECH list is to bring together
scientist and business professionals from industry and academia that work
on
biomedical and biotechnical projects. To share information on ideas,
projects, resources etc., creating a world-wide information and
communication-forum around BIOTECHNOLOGY and its business applications
and opportunities.
Topics of BIZ-BIOTECH include discussion about:
Technology Transfer
Public and private sector R&D efforts and resources
Technical expertise and resources
Technologies available for licensing and/or cooperative R&D
Funding requests
Venture capital sources
Discussion about new product ideas
Announcement of new products on the market
Novel or existing biotechnological companies
Biotechnology stocks
Job opportunities
etc.
Subscribers to this list may be researcher from academia, industry
professionals, clinicians, students and other individuals interested in
the topic of biotechnology and its commercial possibilities. Subscribers
are encouraged to send messages of interest to BIZ-BIOTECH at NETCOM.COM.
Personal messages and personal replies should be sent to an individual
and NOT to the whole list. Otherwise, it might annoy other colleague
BIZ-BIOTECH subscribers. Obviously, replies of general interest should be
send to the entire list.
BIZ-BIOTECH is currently an open, unmoderated list. Any postings are
automatically accepted. The list owner is Stefan Gruenwald (e-mail:
grunwald at netcom.com). Subscribers are encouraged to support BIZ-BIOTECH
actively within their own organizations and personal or professional
net-works. The larger BIZ-BIOTECH becomes, the more useful it will be to
all its subscribers. Commercial messages which are of general interest to
the subscribers are allowed on BIZ-BIOTECH.
For further information about BIZ-BIOTECH, please send an e-mail to
Stefan Gruenwald
(grunwald at netcom.com)
BIZ-BIOTECH listowner
